Memorial Sloan-Kettering Cancer Center (MSKCC)

Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital.

The promise of stem cell technologies for treating Parkinson’s

Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD) in future. Writing in an open access special supplement to the Journal of Parkinson’s Disease, experts describe how

The promise of stem cell technologies for treating Parkinson’s

Fecal microbiota transplantation could offset harsh effects of antibiotics in cancer patients

NIAID-funded study could offset harsh effects of antibiotics. Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the

Fecal microbiota transplantation could offset harsh effects of antibiotics in cancer patients

Using ultrasound to remotely control a cancer immunotherapy system

A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells. There is a critical need to non-invasively and remotely manipulate cells at a distance, particularly for translational applications in animals and humans, researchers said. The

Using ultrasound to remotely control a cancer immunotherapy system

Complete cure for colorectal cancer?

Novel three-step pretargeted radioimmunotherapy offers safe, effective treatment Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a 100-percent cure rate—without any

Complete cure for colorectal cancer?

A new way to combat cancer at the cellular level: Block it

New findings published in Nature Chemical Biology show promise for finding new solutions to treat lung cancer and other deadly diseases. Kentucky continues to lead the nation in incidence and death rates from lung cancer, and the University of Kentucky is committed to reducing these numbers. According to the National Cancer Institute, cancer is among the leading causes

A new way to combat cancer at the cellular level: Block it

A single gene turns colorectal cancer cells back into normal tissue in mice

Anti-cancer strategies generally involve killing off tumor cells. However, cancer cells may instead be coaxed to turn back into normal tissue simply by reactivating a single gene, according to a study published June 18th in the journal Cell. Researchers found that restoring normal levels of a human colorectal cancer gene in mice stopped tumor growth and

A single gene turns colorectal cancer cells back into normal tissue in mice

‘Huge breakthrough’ in understanding how the immune system recognises cancer

US researchers have revealed(link is external) the identity of molecules on the surface of cancer cells which allow the body’s immune system to identify and destroy them. The research could lead to a new generation of immunotherapies that are far more effective than those currently in use, that could target a range of cancers. “This

‘Huge breakthrough’ in understanding how the immune system recognises cancer

Handheld scanner could make brain tumor removal more complete, reducing recurrence

Cancerous brain tumors are notorious for growing back despite surgical attempts to remove them — and for leading to a dire prognosis for patients. But scientists are developing a new way to try to root out malignant cells during surgery so fewer or none get left behind to form new tumors. The method, reported in

Handheld scanner could make brain tumor removal more complete, reducing recurrence

Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated

Cell Therapy Shows Remarkable Ability to Eradicate Cancer in Clinical Study Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated

Genetically Modified T Cells Induced Complete Remissions in 88 Percent of Advanced Leukemia Patients Treated

Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the ICU

Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in

Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the ICU

New Breakthrough Prize Awards Millions to Life Scientists

Eleven scientists became multimillionaires this morning when they were named the first winners of the new Breakthrough Prize in Life Sciences. Each researcher, whose specialties include genetics, stem cells, and cancer, will receive $3 million dollars, more than twice the maximum amount of a Nobel Prize. Funded by several Silicon Valley entrepreneurs, including Arthur Levinson

New Breakthrough Prize Awards Millions to Life Scientists

Potential Cancer Diagnostic Tool Set for Human Trials

The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging. A paper describing this new medical technology is published online in the Journal of Clinical Investigation (July 2011). This is a collaboration

Potential Cancer Diagnostic Tool Set for Human Trials

The Latest Bing News on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Research

Memorial Sloan Kettering Doctor Talks Cancer Care on Long Island
We talked with Dr. Diane Reidy-Lagunes about cancer, cures, Covid, the pandemic, and efforts to serve Long Islanders closer to home.
For home health agencies, results of vaccine mandate are a mixed bag
Plus: Staten Island University Hospital gets OK for $139M women and newborn center Exclusive: Brooklyn College launches $9M cancer center ProHealth Dental inks clinical affiliation with Catholic Healt ...
Diagnosing Ovarian Cancer with Carbon Nanotubes
Learn more about research innovations that are exploring the potential of carbon nanotubes-based nanosensors to improve ovarian cancer diagnosis.
What's the Best Way to Treat Femur Breaks From Bone Metastases?
The use of long-stem hemiarthroplasty (LSHA) did not improve quality-of-life (QoL) or functional outcomes compared to intramedullary nailing (IMN) in treating pathological fractures of the ...
Researchers Uncover New Findings about KRAS, an Important Protein in Cancer
Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.

The Latest Google Headlines on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Research

The Latest Bing News on:

Memorial Sloan-Kettering Cancer Center (MSKCC) Discovery

Some Dana-Farber Cancer Institute trustees stood to profit from their philanthropic role
Access to trustee investments and market expertise can help the hospital. But this practice creates potential conflicts of interest at the highest level of an institution and worries about whether ...
Researchers Uncover New Findings about KRAS, an Important Protein in Cancer
In a study published October 8, 2021, in Science, researchers from Memorial Sloan Kettering Cancer Center took a closer look at what ... Yet despite that early discovery, progress to develop ...
GNS Healthcare Announces a Multi-Year Collaboration with a Leading US Cancer Center to Advance Precision Medicine in Oncology
GNS today announced a multi-year collaboration with MSK to leverage prostate cancer patient data with GNS’ Gemini in silico Prostate Cancer patient.
Memorial Sloan Kettering Cancer Center receives Healthcare Leaders of New York (HLNY) Diversity Leader Award
The Healthcare Leaders of New York (HLNY) announced (MSK) as their 2021 Diversity Leader Award recipient. The award ...
Deb Schrag, MD, MPH, Named Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center
Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished ... fertilize a culture that supports innovation and ...